To include your compound in the COVID-19 Resource Center, submit it here.

ViroPharma reports earnings, Cinryze guidance

ViroPharma Inc. (NASDAQ:VPHM) reported diluted GAAP EPS of $0.20, beating by $0.02 the Street's estimate of $0.18, but down 31%

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE